Free CME

Treatment Updates on Chronic Inflammatory Demyelinating Polyneuropathy emphasizes the use of IVIg in the treatment of Chronic Inflammatory Demyelinating Polyneuropathy.

The presentation consists of a single lecture, Treatment Updates on Chronic Inflammatory Demyelinating Polyneuropathy, with discussion by Roy L. Freeman, MD, Richard J. Barohn, MD and Kenneth C. Gorson, MD.

After viewing Treatment Updates on Chronic Inflammatory Demyelinating Polyneuropathy, you will be better able to :
• Conduct a thorough and timely evaluation and differential diagnosis of patients with chronic inflammatory demyelinating polyneuropathy.
• Devise appropriate treatment regimen for the effective management of chronic inflammatory polyneuropathy based on guidelines and clinical evidence.

Target Audiences:
This program is intended for US-based neurologists, immunologists, physician assistants, nurse practitioners, and nurses who manage, or have an interest in managing patients with immune-mediated neuropathies.

Activity Description / Statement of Need:

In this online, self-learning activity:

Beta-thalassemia (BT) is a progressive, hereditary, microcytic, hypochromic form of anemia characterized by the reduced synthesis of hemoglobin subunit beta and the underproduction of hemoglobin A (HbA). Although there are limited data regarding the incidence of BT, historical estimates of BT have been placed at about 1 in 100,000 individuals. BT is most commonly found in patients with Mediterranean, the Middle Eastern, Central Asian, Indian, East Asian, and the North African heritage. BT is caused by a point mutation in the encoding gene for hemoglobin subunit beta (HBB) on chromosome 11, which either results in lower beta-globin production (termed beta-plus [B⁺] or prevent cells from producing any beta-globin at all (termed beta-zero [B⁰]). The clinical severity the disease depends on the extent of β and γ chain imbalance; more than 350 genetic alterations that can cause BT have been identified.

There is a demonstrated variation in treatment between providers who practice at a beta thalassemia center of excellence (CoE) and those who do not, and those practitioners at CoEs demonstrate greater familiarity with beta thalassemia and its therapies, including butyrates, gene therapy, and luspatercept. Additional areas of educational need include transitioning patients from pediatric care, management of complications, and clinical trial updates.

Target Audience:

The following healthcare professionals: hematologists; physician assistants, nurse practitioners, and pharmacists who practice in hematology; and any other healthcare professionals with an interest in or who may clinically encounter patients with BT.

This online learning module is designed to raise awareness for HCM and provide an understanding of the need to screen and the types of screening for HCM.

AdvancingIn offers CME activities in many areas including:
Women’s Health; Lung Health; Endocrinology, Metabolism and Diabetes; Rheumatology; Cardiovascular Health; Paediatric Health; Pain Management; Obesity; Medication Management; and Eye Health.

Target Audience: Most Specialties

AIMS: Advances in Multiple Sclerosis is designed to provide high-quality, up-to-date information on advances in the treatment of MS. The following topics are discussed:
• The latest clinical information on the management of MS patients, patient education tools, and resources
• Early MS/CIS/RIS
• Switching Therapy and JCV
• Recent Advances in Treating Multiple Sclerosis: Efficacy, Risks and Place in Therapy
• Monitoring and Improving Patient Adherence to Therapy
• Vitamin D Status Predicts New Brain Magnetic Resonance Imaging Activity in Multiple Sclerosis

Target Audience:
Neurologists, nurse practitioners, physician assistants, nurses, other health care providers involved in the management of MS.

This case study features expert discussion surrounding a real HCM patient and is designed to raise disease awareness and provide an understanding of the risk factors for sudden cardiac death in pediatric HCM patients.

BroadWater offers CME webinars and meetings.

Examples of topics covered are:
• Basic Orthopaedic Principles
• Foot and Ankle Pain: Evaluation and Management
• Hand and Wrist Pain: Evaluation and Management
• Hip Disorders: Evaluation and Management
• Knee Disorders: Evaluation and Management
• Pediatric Upper and Lower Extremity Disorders
• Shoulder and Elbow Pain: Evaluation and Management

Target Audience: Neurologists, Neurosurgeons, and Orthodontists.

Some recent topics include:
• Cancer Screening in the United States, 2013
• Risk Factors, Pathophysiology, and Treatment of Hot Flashes in Cancer
• American Cancer Society Lung Cancer Screening Guidelines
• The Role of Human Papillomavirus in Nongenital Cancers
• Hypnosis for Cancer Care: Over 200 Years Young
• The Current Status of Robotic Oncologic Surgery
• Oral Complications of Cancer and Cancer Therapy: From Cancer Treatment to Survivorship
• Electronic Patient-Reported Outcome Systems in Oncology Clinical Practice
• Nutrition and Physical Activity Guidelines for Cancer Survivors

Target Audience: Oncologists

Contains seven disease-based interactive modules:
Chlamydia, Gonorrhea, Herpes Simplex Virus (HSV), Human Papilloma Virus (HPV), Pelvic inflammatory Disease (PID), Syphilis and Vaginitis.

Target Audience:
Physicians focusing on Family Medicine, Internal Medicine, OB-GYN, Infectious Disease

After login, Choose “Search.” You may then search for courses by date, keyword, or display all. Searching keyword “Web on Demand” will bring you to a list of online courses on public health and preventive medicine topics with an emphasis on vaccination.

Target Audience: Physicians focusing on Preventive Medicine, Infectious Disease